Translating localized renal reprogramming to systemic protection: A comprehensive review of SGLT2 inhibitors in cardiovascular-kidney-metabolic syndrome

Precision Medication · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles